PJFZX
Price
$66.35
Change
+$0.02 (+0.03%)
Updated
May 9 closing price
Net Assets
8.07B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

PJFZX vs RGAHX

Header iconPJFZX vs RGAHX Comparison
Open Charts PJFZX vs RGAHXBanner chart's image
PGIM Jennison Growth Z
Price$66.35
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets8.07B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
PJFZX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PJFZX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PJFZX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. PJFZX (8.07B). RGAHX pays higher dividends than PJFZX: RGAHX (0.54) vs PJFZX (0.00). PJFZX was incepted earlier than RGAHX: PJFZX (29 years) vs RGAHX (9 years). PJFZX (0.69) is less costly to investors than RGAHX (0.44). PJFZX is a more actively managed with annual turnover of: 37.00 vs. RGAHX (25.00). PJFZX has a lower initial minimum investment than RGAHX: PJFZX (0) vs RGAHX (250). RGAHX annual gain was more profitable for investors over the last year : 3.25 vs. PJFZX (1.10). RGAHX return over 5 years is better than : 44.87 vs. PJFZX (38.32).
PJFZXRGAHXPJFZX / RGAHX
Total Expense Ratio0.690.44157%
Annual Report Gross Expense Ratio0.690.44157%
Fund Existence29 years9 years-
Gain YTD-4.436-2.478179%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets8.07B285B3%
Annual Yield % from dividends0.000.54-
Returns for 1 year1.103.2534%
Returns for 3 years45.5433.40136%
Returns for 5 years38.3244.8785%
Returns for 10 years103.94N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics